Cite

HARVARD Citation

    Riccardi, F. et al. (2013). 18FDG-PET for Early Prediction of Complete Response to Lapatinib and Capecitabine in HER2-Positive Metastatic Breast Cancer: A Case Report. Tumori. 99 (6), pp. e257-e260. [Online]. 
  
Back to record